243
23
14
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9577 |
HCV-IN-31
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
HCV-IN-31 是一种HCV 抑制剂,EC50/EC95值为15.7 μM。 | |||
T11541 |
HCV-IN-30
|
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
HCV-IN-30 是 HCV NS5A 复制复合物的抑制剂(基因型 1a 和 1b 复制子的 IC50 = 901 和 102 nM)。 | |||
T11539 |
HCV-IN-29
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
HCV-IN-29 是一种丙型肝炎病毒抑制剂。 | |||
TQ0090 |
Nesbuvir
HCV-796 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Nesbuvir 是一种选择性丙型肝炎病毒(HCV)非结构蛋白5B(NS5B)RNA 依赖性聚合酶抑制剂。Nesbuvir 对含1b HCV 复制子的肝癌细胞的 IC50为9nM。 | |||
T32050 |
HCV-371
HCV 371 |
Others | Others |
HCV-371 is a potent selective HCV NS5B polymerase inhibitor that shows broad inhibitory activity against NS5B RDRP and no inhibitory activity against a set of human polymerases (including mitochondrial DNA polymerase γ and other unrelated viral polymerase | |||
T27530 |
HCV-086
HCV086 |
Others | Others |
HCV-086, a RNA-directed RNA polymerase (NS5B) inhibitor, is used for the treatment of HCV infection. | |||
T11540 |
HCV-IN-3
|
Others | Others |
HCV-IN-3 is a hepatitis C virus (HCV) NS3/4a protein inhibitor (IC50: 20 μM; Kd: 29 μM). | |||
T11548 |
HCV-IN-7
|
Others | Others |
HCV-IN-7 is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. | |||
TP1468 |
HCV-IN-4
|
||
HCV-IN-4, a potent and orally active inhibitor of HCV NS5A, demonstrates significant efficacy against genotypes GT1a, GT2b, GT3a, and the GT1a mutations Y93H and L31V. Its half-maximal effective concentrations (EC90s) are 3 pM, 0.3 nM, 0.01 nM, 0.5 nM, and 0.02 nM, respectively[1]. | |||
T11548L |
HCV-IN-7 hydrochloride
|
Others | Others |
HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. | |||
T79626 |
HCV-IN-44
|
Others | Others |
HCV-IN-44(化合物28)为一种针对HCVNS5B蛋白的抑制剂,能够有效阻止丙型肝炎病毒(HCV)的复制。此化合物主要应用于HCV感染的相关研究。 | |||
T63407 |
HCV-IN-36
|
Others | Others |
HCV-IN-36 是口服具有活力的HCV 进入抑制剂,表现出良好的抗病毒作用 (EC50: 0.016 μM, CC50: 8.78 μM)。 | |||
T63566 |
HCV-IN-33
|
Others | Others |
HCV-IN-33 (Compound (S)-3i) 是 HCV 进入抑制剂。 | |||
T63567 |
HCV-IN-34
|
Others | Others |
HCV-IN-34 是口服具有活力的 HCV 进入抑制剂。HCV-IN-35 表现出良好的抗病毒效果 (EC50: 0.010 μM, CC50: 7.50 μM)。 | |||
T63406 |
HCV-IN-35
|
Others | Others |
HCV-IN-35 是 HCV 的有效抑制剂,表现出潜力进行感染性疾病的研究。 | |||
T64202 |
HCV-IN-40
|
Others | Others |
HCV-IN-39 (Compound 18a) 是一种有效的、口服具有活力的 hepatitis C virus (HCV) 核苷抑制剂,能够作用于 GT1a 复制子 (EC50: 0.259 μM)、GT1b 复制子 (EC50: 0.434 μM) 和 GT1b CES1 复制子 (EC50: 0.069 μM)。 | |||
T79625 |
HCV-IN-43
|
Others | Others |
HCV-IN-43(化合物2)为HCVNS5B蛋白抑制剂,有效抑制丙型肝炎病毒(HCV)复制,适用于HCV感染研究。 | |||
T63585 |
HCV-IN-37
|
Others | Others |
HCV-IN-37 是 HCV 的有效抑制剂。HCV-IN-37 以 15 mg/kg 的单剂量对大鼠口服给药后,能够在大鼠血浆中持久存在。活性衍生物 HCV-IN-37 的高效力主要是由对病毒进入阶段的抑制作用驱动。 | |||
T63396 |
HCV-IN-38
|
Others | Others |
HCV-IN-38 是选择性的、有效的、口服具有活力的丙型肝炎病毒 (HCV) 抑制剂,其EC50值为15 nM,SI 值为431。HCV-IN-38 具有良好的安全性及口服药代动力学,表现出较高的抗HCV 活性和较低的细胞毒性作用。 | |||
T74625 |
HCV-IN-41
|
Others | Others |
HCV-IN-41 (compound 4) 是一种高效的丙肝病毒 (HCV)抑制剂,对 HCV1b、2a、3a 和 4a 的 EC50分别为 0.006762 nM、5.183 nM、1.365 nM 和 142.2 nM。HCV-IN-41 能降低 HCVRNA 的复制。 | |||
T76518 |
HCV Peptide (131-140)
|
||
HCVPeptide (131-140) 是一种肽。HCVPeptide (131-140) 可用于丙型肝炎病毒(HCV)的研究。 | |||
T3489 |
Dasabuvir
ABT-333,达塞布韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dasabuvir (ABT-333) 是丙型肝炎病毒非结构蛋白 5B 的非核苷抑制剂,是一种 RNA 依赖性 RNA 聚合酶,具有抗 HCV 的潜在活性。 | |||
T76520 |
HCV Peptide (257-266)
|
||
HCVPeptide (257-266) 是一种肽。HCVPeptide (257-266) 可用于丙型肝炎病毒(HCV)的研究。 | |||
T76519 |
HCV Peptide (35-44)
|
||
HCVPeptide (35-44)为HCV核心蛋白的35至44位段,具有HLA-A2限制性CTL表位功能。该肽段通过KIR2DL2/3直接抑制NK细胞活性,以及协同CD94:NKG2A受体抑制NK细胞活性。 | |||
T38237 |
2′-O-Methylcytidine
|
Nucleoside Antimetabolite/Analog; HCV Protease | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
2'-O-Methylcytidine 是 2'-代核苷,可抑制 HCV 复制。 它在体外抑制 NS5B 催化的 RNA 合成,其抑制方式是与底物核苷三磷酸竞争。 | |||
T5126 |
Glecaprevir
ABT-493 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Glecaprevir (ABT-493) 是一种新型的 HCV NS3/4A 蛋白酶抑制剂,其 IC50值在 3.5 和 11.3 nM 之间。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 4.09 μM。 | |||
T76522 |
HCV Core Protein (59-68)
|
||
HCVCore Protein (59-68) 是一种含有 HCV 核心蛋白 59-68 残基的肽。 | |||
T4197 |
HZ-1157
HZ1157,DHFR-inhibitor |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
HZ-1157 (DHFR-inhibitor) 是一种丙型肝炎病毒抑制剂,对 HCV NS3/4A 蛋白酶具有抑制活性。 | |||
T19862 |
Voxilaprevir
维昔普维,伏西瑞韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Voxilaprevir 是丙型肝炎病毒非结构蛋白 3/4A 蛋白酶的抑制剂,具有抗病毒活性。它抑制基因型 1b 和 3a 野生型 NS3 蛋白酶的 Ki 值分别为 0.038 nM 和 0.066 nM。 | |||
T76523 |
HCV Core Protein (107-114)
|
||
HCVCore Protein (107-114) 是主要线性 HCV 核心区域中免疫原性极低的残基。HCVCore Protein (107-114) 被鉴定为 101-118 区域内的结合位点,其包含基因型 Ⅰ/Ⅱ 和基因型 Ⅲ/Ⅵ 之间不同的两个残基。HCVCore Protein (107-114) 可能是传播 HCV 血清型的潜在位点。 | |||
T1822 |
Clemizole
克立咪唑,吡咯咪唑 |
HCV Protease; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Clemizole 是一种 H1 组胺受体拮抗剂,可抑制 NS4B 的 RNA 结合和丙型肝炎病毒复制。它也是TRP5通道抑制剂。 | |||
T4547 |
Grazoprevir
MK-5172 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Grazoprevir (MK-5172) 是一种丙型肝炎病毒 NS3/4a 蛋白酶的选择性抑制剂,具有跨基因型和耐药变体的广泛活性,对 gt1b、gt1a、gt2a、gt2b 和 gt3a 的Ki 分别为 0.01 nM、0.01 nM、0.08 nM、0.15 nM 和 0.90 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T17190 |
U18666A
|
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
U18666A 是一种细胞渗透性药物,是一种胆固醇合成和转运抑制剂,抑制埃博拉病毒,登革热病毒和人类丙型肝炎病毒的复制。 | |||
T5938 |
4-Phenoxybenzylamine
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
4-Phenoxybenzylamine 通过稳定无活性构象来抑制NS3蛋白的功能,对 HCV NS3/4a 的 IC50 约为 500 μM。 | |||
T4474 |
Asunaprevir
BMS-650032,阿那匹韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Asunaprevir (BMS-650032) 是一种有口服活性的 HCV NS3 蛋白酶抑制剂,IC50值为 0.2 nM-3.5 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T1822L |
Clemizole hydrochloride
克立咪唑盐酸,盐酸克立咪唑 |
HCV Protease; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Clemizole hydrochloride 是一种 TRPC5通道的抑制剂。它还是一种 H1 组胺受体拮抗剂,抑制 HCV 复制。 | |||
T76514 |
HCV-1 e2 Protein (554-569)
|
||
HCV-1 e2 Protein (554-569) 是一段重要的丙型肝炎病毒(HCV) e2 蛋白的抗原区域,具有一个推定的 N-糖基化位点,这个位点被认为之前影响了e2蛋白的免疫识别。 | |||
T76516 |
HCV-1 e2 Protein (484-499)
|
||
HCV-1 e2 蛋白 (484-499) 是由 16 个氨基酸组成的肽。 HCV-1 e2 蛋白 (484-499) 来源于具有 HCV 抗体的个体血清中丙型肝炎病毒的包膜 2 蛋白。 | |||
T76521 |
HCV NS4A Protein (18-40) (JT strain)
|
||
HCVNS4A Protein (18-40) (JT strain) 为HCVNS4A 肽,由第18至40个NS4A蛋白残基构成,能够增强NS3蛋白酶的催化效率。 | |||
T22394 |
Paritaprevir
ABT450,ABT-450,帕利普韦,Veruprevir |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Paritaprevir (ABT450) 是一种非结构蛋白 3/4A 蛋白酶抑制剂,对 HCV 1a 和 HCV 1b 的 EC50 值分别为 1 和 0.21 nM。它也是SARS-CoV 3CLpro 的抑制剂,IC50为 1.31 μM。 | |||
T15573 |
Inarigivir soproxil
SB9200 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Inarigivir soproxil (SB9200) 是一种先天免疫激动剂。 它还显示出针对耐药丙型肝炎病毒 (HCV) 变体的有效抗病毒活性。在基因型 1 HCV 复制子系统细胞中, HCV 1a/1b 的 EC50 为 2.2 和 1.0 μM。 | |||
T4988 |
Boceprevir
SCH 503034,EBP 520,波普瑞韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Boceprevir (SCH 503034) 是一种口服有效的选择性 HCV NS3 蛋白酶抑制剂。在酶试验中的 Ki 为 14 nM,在基于细胞的复制子试验中 EC90 为 350 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T25268L |
Coblopasvir dihydrochloride
Coblopasvir dihydrochloride(1312608-46-0 Free base) |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Coblopasvir dihydrochloride 是一种泛基因型非结构蛋白 5A(NS5A)抑制剂。本品可用于慢性丙型肝炎病毒感染的研究。 | |||
T16088 |
MK-0608
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
MK-0608 是一种可口服的体外 HCV 复制抑制剂。在亚基因组复制子测定中,EC50值为 0.3 μM,EC90值为 1.3 μM。 | |||
T80089 |
HCV-1 e2 Protein (554-569) (TFA)
|
||
HCV-1 e2 Protein (554-569) TFA 为丙型肝炎病毒(HCV)e2 蛋白关键抗原区段,含一个假定 N-糖基化位点,该位点早先推测会影响 e2 蛋白的免疫识别。 | |||
T9567 |
Samatasvir
ATOLIHZIXHZSBA-BTSKBWHGSA-N,IDX719 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Samatasvir (ATOLIHZIXHZSBA-BTSKBWHGSA-N) 是 NS5A HCV 复制抑制剂。它能够有效的选择复制子及感染性 HCV,在基因型 1至5 复制子中,EC50= 2~24 pM。 | |||
T6190 |
Telaprevir
VX-950,LY-570310,Incivek,MP-424,特拉匹韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Telaprevir (Incivek) 是一种选择性可逆的HCV NS3-4A 蛋白酶抑制剂,作用于基因 1型 (H 株) NS3 蛋白酶结构域和 NS4A 辅因子肽,Ki 为 7 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T4544 |
Elbasvir
MK-8742 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Elbasvir (MK-8742) 是丙型肝炎病毒的非结构蛋白 5A 抑制剂,可用于治疗慢性 HCV 感染。 | |||
T1565 |
Deferiprone
去铁酮,Deferidone,CP20 |
Others; HCV Protease; Ferroptosis; UGT | Apoptosis; Metabolism; Microbiology/Virology; Others; Proteases/Proteasome |
Deferiprone (Deferidone) 是口服活性铁螯合剂,可研究地中海贫血中的输血性铁过载。 | |||
T0013 |
Mecarbinate
优多降,Dimecarbine,Dimecarbin,美卡比酯 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Mecarbinate 是一种吲哚衍生物,具有抗 HCV 活性和免疫调节作用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S1598 |
Mulberroside C
桑皮苷 C,桑皮苷C |
Antioxidant; HCV Protease | Microbiology/Virology; oxidation-reduction; Proteases/Proteasome |
Mulberroside C 是桑树中的主要生物活性成分之一,可抑制 HCV 复制,具有抗病毒活性。 | |||
T2770 |
Gentiopicroside
Gentiopicrin,龙胆苦甙,龙胆苦苷 |
P450; HCV Protease | Metabolism; Microbiology/Virology; Proteases/Proteasome |
Gentiopicroside (Gentiopicrin) 是天然环烯醚萜苷,具有抗炎和抗氧化活性。它抑制P450的活性,对 CYP2A6 的 IC50和 Ki 值分别为 61 µM 和 22.8 µM, | |||
T3810 |
Saikosaponin B2
柴胡皂苷 B2,柴胡皂甙 B2 |
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
Saikosaponin B2 是从柴胡根中分离得到的一种活性成分,可抑制 HCV 病毒感染的侵入,有抗癌作用。 | |||
TN2089 |
Platycodin D3
桔梗皂苷D3,桔梗皂苷 D3 |
HCV Protease; NF-κB | Microbiology/Virology; NF-κB; Proteases/Proteasome |
Platycodin D3 是桔梗中有抗HCV 活性的一种三萜皂苷类天然产物。 | |||
T3001 |
Honokiol
和厚朴酚,NSC 293100 |
ERK; HCV Protease; MEK; Akt; Autophagy | Autophagy; Cytoskeletal Signaling; MAPK; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Honokiol (NSC-293100) 是厚朴提取物的活性成分,靶向多种信号分子,具有抗氧化,抗炎,抗血管生成和抗癌活性。它可抑制 Akt 的激活并增强 ERK1/ERK2 的磷酸化。 | |||
T7607 |
PSI-6130
R 1656,2'-去氧-2'-氟-2'-C-甲基胞苷 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
PSI-6130 (R 1656) 是高效选择性 HCV NS5B 聚合酶抑制剂,抑制 HCV 复制,IC50值为 0.6 μM。 | |||
T3821 |
Deapioplatycodin D
Deapi-platycodin D,去芹糖桔梗皂苷 D,去芹糖桔梗皂苷D,DesapioplatycodinD |
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
Deapioplatycodin D 是从桔梗中分离出的一种三萜皂苷,具有抗丙型肝炎病毒活性。 | |||
TN6732 |
Oenothein B
|
Apoptosis; HCV Protease; Antibacterial; Antifungal | Apoptosis; Microbiology/Virology; Proteases/Proteasome |
Oenothein B 是一种聚(ADP-核糖)糖水解酶的特异性抑制剂。 Oenothein B 具有抗氧化、抗炎、抗真菌、抗 HCV 和抗肿瘤特性。 | |||
T0392 |
Artemisinin
Qinghaosu,Artemisinine,Qinghaosu,NSC 369397,青蒿素,Artemisinine |
HCV Protease; Ferroptosis; Akt; Parasite | Apoptosis; Cytoskeletal Signaling; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Artemisinin (Qinghaosu) 是一种倍半萜烯内酯,是从青蒿植物的地上部分分离的一种抗疟疾药物。它有神经保护和抗癌作用。 | |||
T1188 |
Mizoribine
Bredinin,NSC 289637,咪唑立宾,HE 69 |
HCV Protease; SARS-CoV; Tyrosinase | Microbiology/Virology; Proteases/Proteasome |
Mizoribine (NSC-289637) 是一种免疫抑制剂,抑制HCVRNA 复制,有抗 HCV 活性,IC50约为 100 μM。它抑制SARS-CoV 复制,对 SARS-CoV Frankfurt-1 和 SARS-CoV HKU39849 的 IC50分别为 3.5 μg/mL 和 16 μg/mL。 | |||
T7203 |
Oglufanide
奥谷法奈,L-Glutamyl-L-tryptophan,H-Glu-Trp-OH |
VEGFR; HCV Protease; Endogenous Metabolite | Angiogenesis; Metabolism; Microbiology/Virology; Proteases/Proteasome; Tyrosine Kinase/Adaptors |
Oglufanide (H-Glu-Trp-OH) 是一种从小牛胸腺中分离出来的二肽免疫调节剂,可抑制血管内皮生长因子,可刺激细胞内细菌感染和对丙型肝炎病毒的免疫反应。 | |||
TN1033 |
Sennidin A
|
HCV Protease; transporter; Akt; PI3K | Cytoskeletal Signaling; Metabolism; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Sennidin A 是从狭叶番泻分离得到的一种天然产物,能够抑制 HCV NS3 解旋酶,其 IC50值为0.8 μM。它诱导 Akt 和葡萄糖转运蛋白4的磷酸化,刺激葡萄糖掺入。 | |||
TN1034 |
Sennidin B
|
HCV Protease; transporter; Akt; PI3K | Cytoskeletal Signaling; Metabolism; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Sennidin B 是从Cassia angustifolia 分离得到的Sennidin A 异构体,它刺激葡萄糖掺入,诱导Akt 和葡萄糖转运蛋白4 的磷酸化。 | |||
TN7356 |
THCVA-A
Δ1-Tetrahydrocannabivarinic A |
Others | Others |
THCVA-A is a natural product and can be used as a standard reference. | |||
T38375 |
Pseudane IX
2-nonyl-4-hydroxyquinoline,2-nonyl-1H-quinolin-4-one,2-nonyl-4(1h)-quinolone |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Pseudane IX (2-nonyl-1H-quinolin-4-one) 可减少丙型肝炎病毒 (HCV) 对 Huh 7.5 细胞的感染,IC50 为 1.4 μg/ml。 | |||
T16165 |
Myriocin
ISP-I,Thermozymocidin |
HCV Protease; Antifungal | Microbiology/Virology; Proteases/Proteasome |
Myriocin (Thermozymocidin) 是一种从 Myriococcum albomyces 中得到的代谢产物,是一种丝氨酸-棕榈酰转移酶 (SPT) 抑制剂,具有潜在的抗肿瘤抗癌和抗寄生虫活性,通过 PI3K/Akt/mTOR 通路调节巨噬细胞极化和功能来抑制肿瘤生长。Myriocin 抑制 HCV 感染,可用于研究神经病变和真菌感染。 | |||
T2774 |
Lycorine hydrochloride
石蒜碱,Licorine hydrochloride,Galanthidine hydrochloride,Narcissine hydrochloride,Lycorine chloride,Amarylline hydrochloride,盐酸石蒜碱 |
Virus Protease; HCV Protease; Antibacterial; Autophagy | Autophagy; Microbiology/Virology; Proteases/Proteasome |
Lycorine hydrochloride (Narcissine hydrochloride) 是黑色素瘤血管生成抑制剂,是一种来自石蒜的主要活性成分,抑制 Hey1B 细胞的有丝分裂增殖,IC50值为 1.2 μM,具有抗肿瘤活性。 | |||
TN6508 |
Trachelogenin
(-)-Trachelogenin |
Virus Protease; c-Myc; HCV Protease; Wnt/beta-catenin | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Microbiology/Virology; Proteases/Proteasome; Stem Cells |
Trachelogenin ((-)-Trachelogenin) 分离自Combretum fruticosum,是一种 HCV 进入抑制剂 具有抗增殖作用,其机制与影响β-Catenin 信号通路中的 β-Catenin、c-Myc 和 GSK3 等关键蛋白的磷酸化有关,且呈浓度依赖性。Trachelogenin具有抗病毒、抗炎和镇痛活性,在 HCVcc 和 HCVpp 模型中的 IC50 分别为 0.325 和 0.259 μg/mL。 | |||
TN1138 |
γ-Fagarine
γ-崖椒碱,gamma-Fagarine |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
gamma-Fagarine possesses moderate levels of anti-HCV activities with IC50 values being 20.4 ± 0.4 ug/ml, respectively. It has sister chromatid exchanges (SCEs)-inducing activity | |||
TN3809 |
Dehydrojuncusol
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. | |||
TN5079 |
Sulochrin
|
HCV Protease; Antifection | Microbiology/Virology; Proteases/Proteasome |
Sulochrin shows antifungal and antibacterial activities, it can inhibit hepatitis C virus (HCV) infection in a dose-dependent manner without any apparent cytotoxicity up to 50 uM. Sulochrin has an inhibitory activity to eosinophil degranulation. | |||
TN4404 |
Ladanein
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ladanein is a phytochemicals inhibitor that is known to disrupt the interactions of core and other hepatitis C virus (HCV) proteins.Ladanein possesses free radicals DPPH and ABTS +.scavenging activity, it also displays moderate (20-40 microM) activities against K562, K562R (imatinib-resistant), and 697 human leukemia cell lines. | |||
TN3438 |
Arborinine
|
HCV Protease; Antifection | Microbiology/Virology; Proteases/Proteasome |
Arborinine shows mild in vitro antibacterial activity, it possesses moderate levels of anti-hepatitis C virus(HCV) activities with the IC50 values being 6.4 ± 0.7 ug/ml. Arborinine shows antifeedant activity against Spodoptera frugiperda. Arborinin shows |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01564 |
Hepatitis C virus (HCV-1a) E2 Protein (His)
HCV-1a E2 |
HCV | HEK293 Cells |
Hepatitis C virus (HCV-1a) E2 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 32 kDa and the accession number is NP_751921.1. | |||
TMPY-04135 |
Hepatitis C virus Envelope Glycoprotein E1/HCV-E1 (subtype 1b, strain HC-J4) Protein (His)
HCV-E1 |
HCV | HEK293 Cells |
Hepatitis C virus Envelope Glycoprotein E1/HCV-E1 (subtype 1b, strain HC-J4) Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 18.7 kDa and the accession number is AAC15725.1. | |||
TMPY-00296 |
Hepatitis C virus (HCV) (serotype 1c,isolate HC-G9) E2 Protein (His)
HCV-1a E2 |
HCV | HEK293 Cells |
Hepatitis C virus (HCV) (serotype 1c,isolate HC-G9) E2 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 32.2 kDa and the accession number is BAA03581.1. | |||
TMPY-05166 |
Hepatitis C virus (HCV) (serotype 1b, isolate HC-J4) Envelope/E2 Protein (His)
HCV-1a E2 |
HCV | HEK293 Cells |
Hepatitis C virus (HCV) (serotype 1b, isolate HC-J4) Envelope/E2 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 32.4 kDa and the accession number is AAC15723.1. | |||
TMPY-00323 |
Hepatitis C virus (HCV-1a) NS3 protease/helicase immunodominant region Protein (aa 1356-1459, GST)
NS3 |
HCV | E. coli |
HCV NS3 displays three enzymatic activities: serine protease, NTPase, and RNA helicase. HCV NS3 serine protease, in association with NS4A, is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS5A, and NS5A-NS5B. HCV NS3 RNA helicase binds to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA stable secondary structure in the template strand (By similarity). Cleaves and inhibits the host antiviral protein MAVS. NS3/NS4A complex also prevents phosphorylation of human IRF3, t... | |||
TMPJ-01273 |
ACY3 Protein, Human, Recombinant (His)
Acylase III,Aminoacylase-3,ACY3,Hepatitis C virus core-bindi... |
Human | E. coli |
Aspartoacylase 3, also known as ACY3, N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming), Acylase III, Aminoacylase-3, Aspartoacylase-2, Aspartoacylase-2, HCV core-binding protein 1 and ASPA2, is a member of the Aspartoacylase subfamily. ACY3 plays an important role in deacetylating mercapturic acids in kidney proximal tubules and acts on N-acetyl-aromatic amino acids.ACY3 is located in the cytoplasm of S2 and S3 proximal tubules and the apical domain of S1 proximal tubules. ACY3 ... | |||
TMPY-02285 |
Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Non-structural/NS2 Protein
NS2 Protein |
H1N1 | E. coli |
Non-structural protein 2 (NS2) plays a crucial role in the hepatitis C virus (HCV) assembly. NS2 was predicted to be composed of three transmembrane (TM) segments. Hepatitis C virus (HCV) nonstructural protein 2 (NS2) is a hydrophobic, transmembrane protein that is required not only for NS2-NS3 cleavage but also for infectious virus production.NS2 protein is essential for hepatitis C virus (HCV) replication. NS2 protein was expressed and purified. Aptamers against NS2 protein were raised and ant... | |||
TMPH-01548 |
IFI6 Protein, Human, Recombinant (B2M & His)
Interferon-induced protein 6-16,IFI6,Interferon alpha-induci... |
Human | E. coli |
Plays a role in apoptosis, negatively regulating the intrinsinc apoptotic signaling pathway and TNFSF10-induced apoptosis. However, it has also been shown to have a pro-apoptotic activity. Has an antiviral activity towards hepatitis C virus/HCV by inhibiting the EGFR signaling pathway, which activation is required for entry of the virus into cells. | |||
TMPH-01104 |
Claudin-9 Protein-VLP, Human, Recombinant (His)
CLDN9,Claudin-9 |
Human | HEK293 Cells |
Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.; (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) entry into hepatic cells. Claudin-9 Protein-VLP, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-10xHis tag. The predicted molecular weight is 24.2 kDa and the accession number is O95484. | |||
TMPH-00848 |
OASL Protein, Human, Recombinant (His)
59 kDa 2'-5'-oligoadenylate synthase-like protein,Thyroid re... |
Human | E. coli |
Does not have 2'-5'-OAS activity, but can bind double-stranded RNA. Displays antiviral activity against encephalomyocarditis virus (EMCV) and hepatitis C virus (HCV) via an alternative antiviral pathway independent of RNase L. OASL Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 65.1 kDa and the accession number is Q15646. | |||
TMPH-01248 |
ADAR Protein, Human, Recombinant (His & SUMO)
ADAR1,IFI-4,136 kDa double-stranded RNA-binding protein,Inte... |
Human | E. coli |
Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences duri... | |||
TMPH-00809 |
Hepatitis C Genome polyprotein (His)
Genome polyprotein |
HCV | E. coli |
Hepatitis C Genome polyprotein (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 71.3 kDa and the accession number is S4UAW6. | |||
TMPJ-01330 |
CD299 Protein, Human, Recombinant (His & Flag)
DC-SIGNR,L-SIGN,CD299,CD209L,LSIGN,C-type lectin domain fami... |
Human | HEK293 Cells |
CD299 is also known as DC-SIGNR and CLEC4M, is a type II integral membrane protein. DC-SIGNR exists as a homotetramer, and the tandem repeat domain, also called neck domain, mediates oligermerization. Multiple human DC-SIGN/CD209 splice forms exist, generating both membrane-bound and soluble forms. DC-SIGNR is ragarded as a pathogen-recognition receptor involved in peripheral immune surveillance in liver, and probably mediate the endocytosis of pathogens which are subsequently degraded in lysoso... | |||
TMPY-02193 |
GOLPH2/GOLM1 Protein, Human, Recombinant (His)
HEL46,PSEC0257,GOLPH2,bA379P1.3,C9orf155,GP73,golgi membrane... |
Human | HEK293 Cells |
Golgi membrane protein 1, also known as Golgi membrane protein GP73, Golgi phosphoprotein 2, and GOLM1, is a protein that belongs to the GOLM1 / CASC4 family. GOLM1 is widely expressed. It is highly expressed in the colon, prostate, trachea, and stomach. It is expressed at a lower level in testis, muscle, lymphoid tissues, white blood cells, and spleen. It is predominantly expressed by cells of the epithelial lineage. GOLM1 is expressed at a low level in the normal liver. Expression significantl... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12955 |
Sofosbuvir D6
PSI-7977 D6,GS-7977 D6 |
Others | Others |
Sofosbuvir D6 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. | |||
T26871 |
BMT-052
BMT052 |
||
BMT-052 is a potent and selective Pan-genotypic HCV NS5B Polymerase Inhibitor (EC50 = 7 nM). | |||
T12571 |
PSI-6206 13C,d3
Sofosbuvir metabolite GS-331007 13CD3,RO-2433 13CD3,PSI-6206 13CD3,GS-331007 13CD3 |
Others | Others |
PSI-6206 13CD3 is the deuterium labeled PSI-6206. PSI-6206 is a potent and selective HCV NS5B polymerase inhibitor. | |||
TMIH-0524 |
Sofosbuvir-13C-d3
|
||
Sofosbuvir-13C-d3 是 Sofosbuvir 的 13C 和氘代化合物。Sofosbuvir 的 CAS 号为 1190307-88-0。Sofosbuvir 是一种丙型肝炎病毒聚合酶 NS5B 的尿苷单磷酸类似物抑制剂,用作治疗慢性丙型肝炎的抗病毒剂。 | |||
T38297 |
Ribavirin-13C5
Ribavirin-13C5 |
||
Ribavirin-13C5is intended for use as an internal standard for the quantification of ribavirin by GC- or LC-MS. Ribavirin is an antiviral guanosine nucleoside analog.1,2Upon entry into cells, ribavirin is metabolized to an active triphosphate form that induces viral RNA chain termination and inhibits viral polymerases. It reduces replication in a panel of seven RNA and four DNA viruses in Vero cells (EC50s = 2-95 μg/ml).3Ribavirin also reduces replication of severe acute respiratory syndrome coro... |